Skip to content

Chocolate and CVD Risk in Postmenopausal Women

Chocolate Intake and Heart Disease and Stroke in the Women's Health Initiative: a Prospective Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03453073
Enrollment
83310
Registered
2018-03-05
Start date
2014-12-15
Completion date
2018-07-01
Last updated
2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Heart Disease, Stroke

Keywords

Coronary heart disease, stroke, chocolate consumption, postmenopausal women, nutrition, dietary intake, epidemiology

Brief summary

The investigators will conduct an epidemiological analysis of data from the Women's Health Initiative to investigate the prospective association between chocolate intake and the risk of heart disease and stroke.

Detailed description

BACKGROUND: Three recent meta-analyses found significant prospective inverse associations between chocolate intake and cardiovascular disease risk. Evidence from these meta-analyses suggests that such inverse associations may only apply to elderly individuals or those with preexisting major chronic disease. OBJECTIVE: The investigators will assess the association between habitual chocolate intake and subsequent incident coronary heart disease (CHD) and stroke, and the potential effect of modification by age. DESIGN: The investigators will conduct multivariable Cox regression analyses using data from 83,310 postmenopausal women free of baseline preexisting major chronic disease in the prospective Women's Health Initiative cohort. Chocolate intake was assessed using a food frequency questionnaire. Physician adjudicated events or deaths were ascertained up to September 30, 2013.

Interventions

BEHAVIORALchocolate consumption level

level of consumption of 1 oz. of chocolate, as assessed at baseline

OTHERphysician diagnosis of first occurrence of serious chronic disease

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Department of Health and Human Services
CollaboratorFED
Brooklyn College of the City University of New York
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
55 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

1. Postmenopausal women 2. age between 50 and 79 years 3. enrolled in the Women's Health Initiative (WHI) Observational Study, or in the control arm of one or more overlapping WHI clinical trials.

Exclusion criteria

1. implausible energy intakes, defined as \<600 kcal/d or \>5,000 kcal/d; 2. implausible body mass indices (BMI) (\<15 or \>50 kg/m2) 3. implausible height\<122 cm (4 ft.) 4. self-reported preexisting serious chronic disease at baseline, including diabetes, angina, myocardial infarction (MI), stroke, heart failure, coronary artery bypass graft, percutaneous coronary intervention or cancer. 5. missing data on preexisting major chronic disease or any exposure, outcome or confounder variables.

Design outcomes

Primary

MeasureTime frameDescription
incidence of heart diseasebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 yearsphysician adjudicated first occurrence of, or death due to, heart disease
incidence of strokebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 yearsphysician adjudicated first occurrence of, or death due to, stroke
incidence of heart disease or strokebetween the baseline survey (1993-8) & September 30, 2013, average 13.4 yearsphysician adjudicated first occurrence of, or death due to, heart disease or stroke
change in chocolate intaketime between the baseline and visit 3, average 3 yearschange in chocolate intake between visit 1 and 3
change in dietary energy intaketime between the baseline and year 3, average 3 yearschange in dietary energy intake between visit 1 and 3
change in dietary fat intaketime between the baseline and year 3, average 3 yearschange in dietary fat intake between visit 1 and 3
change in BMItime between the baseline and year 3, average 3 yearschange in BMI between visit 1 and 3

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026